Sort
82,697 grants matching “vaccine development”
Center for AIDS Research
$3,047,509James A Hoxie · University Of Pennsylvania · P30 · FY2012 · AI
Combined Approach to Broadly Protective AIDS Vaccines
$3,047,144Shiu-Lok Hu · University Of Washington · P01 · FY2007 · AI
Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy
$3,046,145Amal O Amer · Ohio State University · P01 · FY2024 · AI
Molecular mechanisms of enterovirus D68 viral entry mediated by the MFSD6 receptor
$3,045,291Jan E Carette · Stanford University · R01 · FY2025 · AI
Shared Resource Management
$3,044,020M. Celeste Simon · University Of Pennsylvania · P30 · FY2023 · CA
B Cell Biology
$3,042,192Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$3,041,682Hildegund C. J. Ertl · Wistar Institute · U19 · FY2010 · AI
Hematopoietic Cell Transplantation for Hematologic Malignancies
$3,041,125Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$3,040,455Mark M Davis · Stanford University · U19 · FY2009 · AI
Project 4: Nuclease Inhibitors for Viruses of Pandemic Concern
$3,040,167Hideki Aihara · University Of Minnesota · U19 · FY2022 · AI
Development of a Safe and Effective Vaccine Against West Nile Virus
$3,039,791Mark K Slifka · Oregon Health & Science University · U01 · FY2011 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,038,595Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Influenza Vaccine Development
$3,038,369Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$3,037,907Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
HIPC Data Coordinating Center
$3,037,897Bjoern Peters · La Jolla Institute For Immunology · U01 · FY2023 · AI
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
$3,036,786Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2009 · AI
Small molecule stimulators for use as adjuvants for antiviral vaccines
$3,035,437Michael J Gale · University Of Washington · N01 · FY2009 · AI
Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans
$3,034,833Anna Karolina Palucka · Baylor Research Institute · U19 · FY2012 · AI
Non-Human Primate Discovery Team
$3,034,308Norman L Letvin · Duke University · U19 · FY2009 · AI
HPV Vaccine Trial
$3,033,861Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Maternal Immunization and Determinants of Infant Immunity
$3,033,683Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2025 · AI
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
$3,032,553Marianna K Baum · Florida International University · U01 · FY2020 · DA
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$3,028,807Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2017 · AI
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
$3,027,841Daniel R Kuritzkes · Massachusetts General Hospital · U01 · FY2010 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$3,025,480Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI